Factor VIII variants having a decreased cellular uptake
US10906960B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2018 |
| Grant date | Feb 2, 2021 |
| Priority date | — |
| Expiry date | Jul 6, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modified coagulation factors. In particular, the present invention relates to modied Factor VIII molecules having decreased cellular uptake.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.